Scientific Publications

Search by Keyword(s)
Found 10 results

Filters: Author is Watanabe, H  [Clear All Filters]

Search Results

  • Showing 1-10 of 10 Results
2016
Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation.Kim, N., Cho A., Watanabe H., Choi YL, Aziz M., Kassner M., Joung JG, Park AK, Francis JM, Bae JS, Ahn SM, Kim KM, Park JO, Park WY, Ahn MJ, Park K., Koo J., Yin HH, and Cho J. Oncotarget, 2016/02/11, (2016) Read More / View Supplemental Materials
Abstract
2015
Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.Zhang, X., Choi PS, Francis JM, Imielinski M., Watanabe H., Cherniack AD, and Meyerson M. Nature genetics, 2015/12/14, (2015) Read More / View Supplemental Materials
Abstract
Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.Lin, W., Watanabe H., Peng S., Francis JM, Kaplan N., Pedamallu CS, Ramachandran A., Agoston A., Bass AJ, and Meyerson M. Molecular cancer research : MCR, 2015/04/01, Volume 13, Issue 4, p.689-98, (2015) Read More / View Supplemental Materials
Abstract
CCAAT/Enhancer Binding Protein β Is Dispensable for Development of Lung Adenocarcinoma.Cai, Y., Hirata A., Nakayama S., VanderLaan PA, Levantini E., Yamamoto M., Hirai H., Wong KK, Costa DB, Watanabe H., and Kobayashi SS PloS one, 2015/01/01, Volume 10, Issue 3, p.e0120647, (2015) Read More / View Supplemental Materials
Abstract
2014
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression.Xu, C., Fillmore CM, Koyama S., Wu H., Zhao Y., Chen Z., Herter-Sprie GS, Akbay EA, Tchaicha JH, Altabef A., Reibel JB, Walton Z., Ji H., Watanabe H., Jänne PA, Castrillon DH, Rustgi AK, Bass AJ, Freeman GJ, Padera RF, et al. Cancer cell, 2014/05/12, Volume 25, Issue 5, p.590-604, (2014) Read More / View Supplemental Materials
Abstract
Breaking Down RET Breakpoints in Lung Adenocarcinoma.Watanabe, H., Brooks AN, and Meyerson M. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2014/05/01, Volume 9, Issue 5, p.590-2, (2014) Read More / View Supplemental Materials
SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas.Watanabe, H., Ma Q., Peng S., Adelmant G., Swain D., Song W., Fox C., Francis JM, Pedamallu CS, Deluca DS, Brooks AN, Wang S., Que J., Rustgi AK, Wong KK, Ligon KL, Liu XS, Marto JA, Meyerson M., and Bass AJ The Journal of clinical investigation, 2014/04/01, Volume 124, Issue 4, p.1636-45, (2014) Read More / View Supplemental Materials
Abstract
2013
Hopping between Differentiation States in Lung Adenocarcinoma.Watanabe, H., and Meyerson M. Cancer cell, 2013/06/10, Volume 23, Issue 6, p.707-9, (2013) Read More / View Supplemental Materials
Abstract
2012
Targeted therapy for squamous cell lung cancer.Liao, RG, Watanabe H., Meyerson M., and Hammerman PS Lung cancer management, 2012/12/01, Volume 1, Issue 4, p.293-300, (2012) Read More / View Supplemental Materials
Abstract
2011
Glioblastoma-Derived Epidermal Growth Factor Receptor Carboxyl-Terminal Deletion Mutants Are Transforming and Are Sensitive to EGFR-Directed Therapies.Cho, J., Pastorino S., Zeng Q., Xu X., Johnson W., Vandenberg S., Verhaak R., Cherniack AD, Watanabe H., Dutt A., Kwon J., Chao YS, Onofrio RC, Chiang D., Yuza Y., Kesari S., and Meyerson M. Cancer research, 2011/12/15, Volume 71, Issue 24, p.7587-96, (2011) Read More / View Supplemental Materials
Abstract
  • Showing 1-10 of 10 Results